Questionnaire and Laboratory Data on Vitiligo Vulgaris
- Conditions
- Vitiligo Vulgaris
- Registration Number
- NCT01206374
- Lead Sponsor
- St. Luke's-Roosevelt Hospital Center
- Brief Summary
Vitiligo vulgaris is an autoimmune disorder that causes loss of pigmentation over the skin, hair and mucous membranes (e.g. lips, nose, genitals). While genes have been identified that are thought to be required for development of vitiligo, only 5-10% of relatives develop disease. The triggers for disease onset have not yet been identified. The intent of this study is to research trends in laboratory data, social and medical history that may be contributory to vitiligo onset, location of disease, course of illness and response to therapy.
- Detailed Description
Patients who participate in this study will be asked to complete a survey and have blood/ laboratory testing performed that relates or may relate to the diagnosis of vitiligo.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 57
- Diagnosis of Vitiligo Vulgaris
- Ability to sign consent
- Pregnant
- Inability to sign consent
- Inability to complete questionnaire
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Quality of life disturbances in people with vitiligo point prevalence dermatology life quality indices were you used and correlated with location of disease
- Secondary Outcome Measures
Name Time Method self-reporting of vitiligo disease symptoms and history single survey Correlation of the patient survey response with chart documentation was performed.
Trial Locations
- Locations (2)
Department of Dermatology, Beth Israel Medical Center
🇺🇸New York, New York, United States
Department of Dermatology, St. Luke's-Roosevelt Hospital Center
🇺🇸New York, New York, United States